COVID-19

In 19 out of 20 patients, a single 1 mcg/kg dose of the drug demonstrated viral clearance as assessed by RT-PCR and a significant…

Social media and cloud computing became the most dominant technologies for current investments for pharma in 2020

The confirmation is based on the first interim data from the double-blind, randomized, placebo-controlled Phase III clinical…

Volunteers will be given transportation, and other care, as well as precautions, will be taken, as endorsed in the guidelines for…

Bamlanivimab allocations to states and territories will be based on their number of hospitalised COVID-19 patients and the number…

The study found that no participants with a high T cell response developed symptomatic SARS-CoV-2 infection when researchers…

 AbCellera’s partner, Eli Lilly and Company, will supply the US government with 300,000 doses of bamlanivimab for allocation to…

Late-stage clinical trials of intranasal COVID-19 vaccines are expected to begin in India in the coming months

Researchers found that some people, notably children, have antibodies reactive to the novel coronavirus SARS-CoV-2 in their blood,…

The scientists behind the RECOVERY trial, which is looking into a range of potential treatments for COVID-19, said it would…